• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在印度尼西亚患者队列中,前列腺癌微环境中肿瘤相关巨噬细胞增多预示着患者的生存率及对雄激素剥夺疗法的反应。

Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients' survival and responses to androgen deprivation therapies in Indonesian patients cohort.

作者信息

Yuri Prahara, Shigemura Katsumi, Kitagawa Koichi, Hadibrata Exsa, Risan Muhammad, Zulfiqqar Andy, Soeroharjo Indrawarman, Hendri Ahmad Z, Danarto Raden, Ishii Aya, Yamasaki Saya, Yan Yongmin, Heriyanto Didik S, Fujisawa Masato

机构信息

Division of Urology, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito Hospital, Jl. Kesehatan No. 1, Yogyakarta, 55281, Indonesia.

Division of Urology, Department of Organ Therapeutics, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.

出版信息

Prostate Int. 2020 Jun;8(2):62-69. doi: 10.1016/j.prnil.2019.12.001. Epub 2020 Feb 10.

DOI:10.1016/j.prnil.2019.12.001
PMID:32647642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7335973/
Abstract

BACKGROUND

Tumor-associated macrophages (TAMs) and microvessel density (MVD) play an essential role for tumor progression in prostate cancer (PCa). In this study, we evaluated the association between TAMs, the infiltration with tumor angiogenesis and the response to androgen deprivation therapies (ADTs) in PCa to evaluate TAM infiltration as a predictive factor for PCa survival.

MATERIALS AND METHODS

Fifty-four specimens were collected and stained with CD 68 antibody to investigated TAM infiltration in tumor. Von Willebrand factor was stained to evaluate MVD around the cancer foci. We assessed the association between patient's age, preoperative serum prostate-specific antigen, pathologic Gleason sum (GS), TAM infiltration, MVD, and the response to ADT for 5 years after PCa diagnosis.

RESULTS

The median TAM was observed in 28 (6-76)/high power field (x400). Increasing TAM correlated with increasing tumor angiogenesis ( < 0.001, r = 0.61), and the response to ADT was significantly better in patients with fewer TAMs (<28) than in patients with higher TAMs (>28) ( = 0.003). TAM infiltration was significantly higher in those with higher serum prostate-specific antigen, higher GS, and metastasis. Multivariate analysis showed that GS, ADT type, and MVD number were significant prognostic factors for response to ADT in PCa ( < 0.0001). An increased infiltration of TAM [hazards ratio (HR) = 4.47; 95% confidence interval (CI): 1.97-10.15], MVD (HR = 2.66; 95% CI: 1.27-5.61), metastatic status (HR = 2.29; 95% CI: 0.14-0.60), and prostate volume (HR = 2.19; 95% CI: 1.27-3.12) significantly correlated with shorter survival in PCa patients by univariate analysis ( < 0.05). Multivariate analyses revealed that TAM and metastatic status significantly correlated with poor overall survival.

CONCLUSIONS

TAM infiltration is associated with response to ADT and increased tumor angiogenesis in PCa. GS, ADT type, and MVD in PCa specimens are useful predictive factors for poor response to ADT. Increasing TAM and positive metastatic status were prognostic factors for a poorer survival in PCa patients.

摘要

背景

肿瘤相关巨噬细胞(TAM)和微血管密度(MVD)在前列腺癌(PCa)的肿瘤进展中起着至关重要的作用。在本研究中,我们评估了TAM、肿瘤血管生成浸润与PCa中雄激素剥夺疗法(ADT)反应之间的关联,以评估TAM浸润作为PCa生存的预测因素。

材料与方法

收集54份标本,用CD 68抗体染色以研究肿瘤中的TAM浸润。用血管性血友病因子染色以评估癌灶周围的MVD。我们评估了患者年龄、术前血清前列腺特异性抗原、病理Gleason评分(GS)、TAM浸润、MVD与PCa诊断后5年ADT反应之间的关联。

结果

在28(6 - 76)/高倍视野(x400)中观察到TAM的中位数。TAM增加与肿瘤血管生成增加相关(<0.001,r = 0.61),TAM较少(<28)的患者对ADT的反应明显优于TAM较高(>28)的患者(= 0.003)。血清前列腺特异性抗原较高、GS较高和有转移的患者中TAM浸润明显更高。多因素分析表明,GS、ADT类型和MVD数量是PCa中ADT反应的重要预后因素(<0.0001)。单因素分析显示,TAM浸润增加[风险比(HR)= 4.47;95%置信区间(CI):1.97 - 10.15]、MVD(HR = 2.66;95% CI:1.27 - 5.61)、转移状态(HR = 2.29;95% CI:0.14 - 0.60)和前列腺体积(HR = 2.19;95% CI:1.27 - 3.12)与PCa患者较短的生存期显著相关(<0.05)。多因素分析显示,TAM和转移状态与总体生存率差显著相关。

结论

TAM浸润与PCa中ADT反应及肿瘤血管生成增加相关。PCa标本中的GS、ADT类型和MVD是ADT反应不佳的有用预测因素。TAM增加和转移状态阳性是PCa患者生存期较差的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/c82c5c1719e0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/84881da8ac5d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/b36e56d993bd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/c82c5c1719e0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/84881da8ac5d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/b36e56d993bd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab15/7335973/c82c5c1719e0/gr5.jpg

相似文献

1
Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients' survival and responses to androgen deprivation therapies in Indonesian patients cohort.在印度尼西亚患者队列中,前列腺癌微环境中肿瘤相关巨噬细胞增多预示着患者的生存率及对雄激素剥夺疗法的反应。
Prostate Int. 2020 Jun;8(2):62-69. doi: 10.1016/j.prnil.2019.12.001. Epub 2020 Feb 10.
2
Association between tumor-associated macrophages and microvessel density on prostate cancer progression.肿瘤相关巨噬细胞与微血管密度与前列腺癌进展的关系。
Prostate Int. 2015 Sep;3(3):93-8. doi: 10.1016/j.prnil.2015.06.002. Epub 2015 Jul 28.
3
Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.巨噬细胞浸润及其在乳腺癌中的预后意义:与VEGF表达和微血管密度的关系。
Oncol Rep. 2005 Aug;14(2):425-31.
4
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
5
Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database.雄激素剥夺治疗期间可检测到的前列腺特异性抗原 nadir 可预测不良的前列腺癌特异性结局:来自 SEARCH 数据库的结果。
Eur Urol. 2014 Mar;65(3):620-7. doi: 10.1016/j.eururo.2012.11.052. Epub 2012 Dec 6.
6
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.早期挽救性放疗后生化复发的前列腺癌患者应用同期雄激素剥夺治疗:一项大型多机构系列研究的长期结果。
Eur Urol. 2018 Apr;73(4):512-518. doi: 10.1016/j.eururo.2017.11.020. Epub 2017 Dec 8.
7
Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.肿瘤相关巨噬细胞浸润与高级别前列腺癌及根治性前列腺切除术后生化复发的相关性。
Am J Cancer Res. 2013 Nov 1;3(5):523-9. eCollection 2013.
8
Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.根治性前列腺切除术和辅助放疗后前列腺癌患者接受雄激素剥夺治疗的最佳 PSA 阈值。
Yonsei Med J. 2020 Aug;61(8):652-659. doi: 10.3349/ymj.2020.61.8.652.
9
[Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy].[去势抵抗性前列腺癌雄激素剥夺治疗后疾病进展时间的预测因素分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Aug 18;49(4):657-662.
10
High infiltration of CD209 dendritic cells and CD163 macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.前列腺癌肿瘤周围区域中 CD209 树突状细胞和 CD163 巨噬细胞的高浸润与晚期不良预后相关。
Front Immunol. 2023 Jun 26;14:1205266. doi: 10.3389/fimmu.2023.1205266. eCollection 2023.

引用本文的文献

1
Macrophages in prostate cancer: dual roles in tumor progression and immune evasion.前列腺癌中的巨噬细胞:在肿瘤进展和免疫逃逸中的双重作用
J Transl Med. 2025 Jun 2;23(1):615. doi: 10.1186/s12967-025-06519-x.
2
Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, , and through NFκB-signaling.M1 巨噬细胞分泌的因子通过 NFκB 信号通路上调 NANOG、SOX2 和 OCT4,从而驱动前列腺癌干细胞的可塑性。
Oncoimmunology. 2024 Aug 21;13(1):2393442. doi: 10.1080/2162402X.2024.2393442. eCollection 2024.
3
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.

本文引用的文献

1
Role of hormonal therapy for prostate cancer: perspective from Japanese experiences.激素疗法在前列腺癌治疗中的作用:来自日本经验的视角
Transl Androl Urol. 2012 Sep;1(3):160-72. doi: 10.3978/j.issn.2223-4683.2012.07.03.
2
Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinoma.交替活化的巨噬细胞与前列腺腺癌的转移和不良预后相关。
Oncol Lett. 2015 Sep;10(3):1390-1396. doi: 10.3892/ol.2015.3400. Epub 2015 Jun 19.
3
Association between tumor-associated macrophages and microvessel density on prostate cancer progression.
促炎细胞因子和 CXC 趋化因子(CXCL1-CXCL16)在前列腺癌进展中的作用:对其治疗管理的深入了解。
Cell Mol Biol Lett. 2024 May 14;29(1):73. doi: 10.1186/s11658-024-00591-9.
4
Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review).肿瘤相关巨噬细胞在肿瘤发生发展中的作用及其作为分子靶点的研究进展(综述)。
Int J Oncol. 2024 Feb;64(2). doi: 10.3892/ijo.2023.5599. Epub 2023 Dec 8.
5
Survival Rate and Prognostic Factors of Localised Prostate Cancer in Southeast Asian Countries: A Systematic Review with Meta-Analysis.东南亚国家局限性前列腺癌的生存率和预后因素:系统评价与荟萃分析。
Asian Pac J Cancer Prev. 2023 Sep 1;24(9):2941-2095. doi: 10.31557/APJCP.2023.24.9.2941.
6
High infiltration of CD209 dendritic cells and CD163 macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.前列腺癌肿瘤周围区域中 CD209 树突状细胞和 CD163 巨噬细胞的高浸润与晚期不良预后相关。
Front Immunol. 2023 Jun 26;14:1205266. doi: 10.3389/fimmu.2023.1205266. eCollection 2023.
7
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.前列腺肿瘤微环境的景观和相关治疗靶点的研究进展。
Acta Biochim Biophys Sin (Shanghai). 2023 Jun 9;55(6):956-973. doi: 10.3724/abbs.2023092.
8
Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy.雄激素剥夺和放疗后前列腺癌组织中的浸润免疫细胞。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231158025. doi: 10.1177/03946320231158025.
9
The Role of Tumor Epithelial-Mesenchymal Transition and Macrophage Crosstalk in Cancer Progression.肿瘤上皮-间充质转化和巨噬细胞串扰在癌症进展中的作用。
Curr Osteoporos Rep. 2023 Apr;21(2):117-127. doi: 10.1007/s11914-023-00780-z. Epub 2023 Feb 27.
10
Inflammation in Urological Malignancies: The Silent Killer.泌尿系统恶性肿瘤中的炎症:沉默的杀手。
Int J Mol Sci. 2023 Jan 3;24(1):866. doi: 10.3390/ijms24010866.
肿瘤相关巨噬细胞与微血管密度与前列腺癌进展的关系。
Prostate Int. 2015 Sep;3(3):93-8. doi: 10.1016/j.prnil.2015.06.002. Epub 2015 Jul 28.
4
Indonesian prostate cancer risk calculator (IPCRC): an application for predicting prostate cancer risk (a multicenter study).印度尼西亚前列腺癌风险计算器(IPCRC):一种预测前列腺癌风险的应用程序(一项多中心研究)。
Acta Med Indones. 2015 Apr;47(2):95-103.
5
A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.间充质样癌细胞与巨噬细胞之间的正反馈环对于乳腺癌转移至关重要。
Cancer Cell. 2014 May 12;25(5):605-20. doi: 10.1016/j.ccr.2014.03.021.
6
The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy.M1和M2巨噬细胞在前列腺癌中与前列腺癌根治术后包膜外肿瘤扩展及生化复发的关系。
Biomed Res Int. 2014;2014:486798. doi: 10.1155/2014/486798. Epub 2014 Mar 11.
7
Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.肿瘤相关巨噬细胞浸润与高级别前列腺癌及根治性前列腺切除术后生化复发的相关性。
Am J Cancer Res. 2013 Nov 1;3(5):523-9. eCollection 2013.
8
Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels.在临床前和临床水平上,乳腺癌和前列腺癌中微血管密度与核异型性、有丝分裂计数及血管侵犯的相关性。
Asian Pac J Cancer Prev. 2013;14(1):63-8. doi: 10.7314/apjcp.2013.14.1.63.
9
Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays.前列腺癌中微血管密度无增加:常规切片和组织微阵列的数字成像。
Hum Pathol. 2013 Apr;44(4):495-502. doi: 10.1016/j.humpath.2012.06.009. Epub 2012 Oct 12.
10
Differentiation and gene expression profile of tumor-associated macrophages.肿瘤相关巨噬细胞的分化与基因表达谱。
Semin Cancer Biol. 2012 Aug;22(4):289-97. doi: 10.1016/j.semcancer.2012.02.002. Epub 2012 Feb 13.